Project BioPatch

Single-use biodegradable continuous health monitoring patch with integrated printed zinc-air micro battery for eldercare facilities and clinical trials.

Asking Enterprise Value

$32.0M

TTM Revenue

$9.2M

YoY Revenue Growth

+52%

Geography

North America / UK

3-Year Financial Trajectory & Margin Analysis

Member Tier Paywall

2023$42,000,000$8,500,00020.2%

2024$61,000,000$14,200,00023.2%

2025$85,000,000$22,000,00025.8%

EBITDA Trajectory Masked

Institutional Member access ($299/mo) is required to view historical EBITDA growth breakdown, QoE audited margins, and request CIM document releases.

Unlock Paid Member Access

Key Investment Merits

FDA 510(k) clearance achieved for continuous cardiac & temperature telemetry.
Patented zinc-air printed battery eliminating lithium-ion toxicity risks.
Unit economics: Manufactured at $1.40/unit, selling at $14.50 to hospital networks.
Ideal acquisition target for medical device conglomerates or digital health platforms.

Virtual Data Room (VDR) Documents

Confidential Information Memorandum (CIM) and financial model packages.

Project BioPatch - CIM & FDA Regulatory Filing Summary.pdf

Category: CIM•Size: 15.1 MB•Dynamic Watermarking Active

Requires Signed NDA & Admin Approval